A SWELL time to develop the molecular pharmacology of the volume-regulated anion channel (VRAC)

Newly emerging roles of LRRC8 volume-regulated anion channels (VRAC) raise important questions about the therapeutic potential of VRAC in the treatment of epilepsy, type 2 diabetes, and other human diseases. A critical barrier to evaluating whether VRAC represents a viable drug target is the lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Figueroa, Eric E., Denton, Jerod S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820792/
https://www.ncbi.nlm.nih.gov/pubmed/35114895
http://dx.doi.org/10.1080/19336950.2022.2033511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820792/
https://www.ncbi.nlm.nih.gov/pubmed/35114895
http://dx.doi.org/10.1080/19336950.2022.2033511

Ejemplares similares